Recent News

May 19, 2020

Timber Pharmaceuticals, Inc., (NYSE American: TMBR), formerly known as BioPharmX Corporation ("Timber" or the "Company"), a biopharmaceutical...

May 12, 2020

Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and commercialization of...

April 6, 2020

Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development...

January 28, 2020

Two privately held biotechs on Tuesday announced plans for reverse mergers, transactions that provide a faster...

July 5, 2019

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) has reached an out-licensing and development agreement with US-based Timber Pharmaceuticals [Timber] for...

January 28, 2020

BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") and Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical...